
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer
Arnaud Blomme, Catriona A. Ford, Ernest Mui, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 149
Arnaud Blomme, Catriona A. Ford, Ernest Mui, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 149
Showing 1-25 of 149 citing articles:
Ferroptosis: machinery and regulation
Xin Chen, Jingbo Li, Rui Kang, et al.
Autophagy (2020) Vol. 17, Iss. 9, pp. 2054-2081
Open Access | Times Cited: 1366
Xin Chen, Jingbo Li, Rui Kang, et al.
Autophagy (2020) Vol. 17, Iss. 9, pp. 2054-2081
Open Access | Times Cited: 1366
The Metabolic Underpinnings of Ferroptosis
Jiashuo Zheng, Marcus Conrad
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 920-937
Open Access | Times Cited: 967
Jiashuo Zheng, Marcus Conrad
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 920-937
Open Access | Times Cited: 967
Ferroptosis at the intersection of lipid metabolism and cellular signaling
Deguang Liang, Alexander M. Minikes, Xuejun Jiang
Molecular Cell (2022) Vol. 82, Iss. 12, pp. 2215-2227
Open Access | Times Cited: 666
Deguang Liang, Alexander M. Minikes, Xuejun Jiang
Molecular Cell (2022) Vol. 82, Iss. 12, pp. 2215-2227
Open Access | Times Cited: 666
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
Fan Yang, Yi Xiao, Jia-Han Ding, et al.
Cell Metabolism (2022) Vol. 35, Iss. 1, pp. 84-100.e8
Open Access | Times Cited: 326
Fan Yang, Yi Xiao, Jia-Han Ding, et al.
Cell Metabolism (2022) Vol. 35, Iss. 1, pp. 84-100.e8
Open Access | Times Cited: 326
The cell biology of ferroptosis
Scott J. Dixon, James A. Olzmann
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 424-442
Closed Access | Times Cited: 305
Scott J. Dixon, James A. Olzmann
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 424-442
Closed Access | Times Cited: 305
Tumour fatty acid metabolism in the context of therapy resistance and obesity
Andrew J. Hoy, Shilpa R. Nagarajan, Lisa M. Butler
Nature reviews. Cancer (2021) Vol. 21, Iss. 12, pp. 753-766
Closed Access | Times Cited: 260
Andrew J. Hoy, Shilpa R. Nagarajan, Lisa M. Butler
Nature reviews. Cancer (2021) Vol. 21, Iss. 12, pp. 753-766
Closed Access | Times Cited: 260
The role of lipids in cancer progression and metastasis
Miguel Martín‐Pérez, Uxue Urdiroz-Urricelqui, Claudia Bigas, et al.
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1675-1699
Open Access | Times Cited: 258
Miguel Martín‐Pérez, Uxue Urdiroz-Urricelqui, Claudia Bigas, et al.
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1675-1699
Open Access | Times Cited: 258
Regulation of ferroptosis by lipid metabolism
Lauren E. Pope, Scott J. Dixon
Trends in Cell Biology (2023) Vol. 33, Iss. 12, pp. 1077-1087
Closed Access | Times Cited: 228
Lauren E. Pope, Scott J. Dixon
Trends in Cell Biology (2023) Vol. 33, Iss. 12, pp. 1077-1087
Closed Access | Times Cited: 228
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis
Zeyad D. Nassar, Chui Y. Mah, Jonas Dehairs, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 147
Zeyad D. Nassar, Chui Y. Mah, Jonas Dehairs, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 147
The diversity and breadth of cancer cell fatty acid metabolism
Shilpa R. Nagarajan, Lisa M. Butler, Andrew J. Hoy
Cancer & Metabolism (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 147
Shilpa R. Nagarajan, Lisa M. Butler, Andrew J. Hoy
Cancer & Metabolism (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 147
Astaxanthin attenuates ferroptosis via Keap1-Nrf2/HO-1 signaling pathways in LPS-induced acute lung injury
Lianxiang Luo, Fangfang Huang, Saiyi Zhong, et al.
Life Sciences (2022) Vol. 311, pp. 121091-121091
Closed Access | Times Cited: 80
Lianxiang Luo, Fangfang Huang, Saiyi Zhong, et al.
Life Sciences (2022) Vol. 311, pp. 121091-121091
Closed Access | Times Cited: 80
Ferroptosis in health and disease
Carsten Berndt, Hamed Alborzinia, Vera Skafar Amen, et al.
Redox Biology (2024) Vol. 75, pp. 103211-103211
Open Access | Times Cited: 75
Carsten Berndt, Hamed Alborzinia, Vera Skafar Amen, et al.
Redox Biology (2024) Vol. 75, pp. 103211-103211
Open Access | Times Cited: 75
Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: new insights from bioinformatics analysis
Cheng Peng, Yanxiu Zhang, Xueyan Lang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62
Cheng Peng, Yanxiu Zhang, Xueyan Lang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62
Mechanisms and regulations of ferroptosis
Xu-Dong Zhang, Zhongyuan Liu, Mao-Sen Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 56
Xu-Dong Zhang, Zhongyuan Liu, Mao-Sen Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 56
Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape
Huocheng Yang, Xuemei Yao, Yingqi Liu, et al.
ACS Nano (2023) Vol. 17, Iss. 16, pp. 15328-15353
Closed Access | Times Cited: 53
Huocheng Yang, Xuemei Yao, Yingqi Liu, et al.
ACS Nano (2023) Vol. 17, Iss. 16, pp. 15328-15353
Closed Access | Times Cited: 53
Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells
Jinxiang Wang, Leli Zeng, Nisha Wu, et al.
Drug Resistance Updates (2023) Vol. 70, pp. 100985-100985
Open Access | Times Cited: 51
Jinxiang Wang, Leli Zeng, Nisha Wu, et al.
Drug Resistance Updates (2023) Vol. 70, pp. 100985-100985
Open Access | Times Cited: 51
Nutritional and Metabolic Control of Ferroptosis
Eikan Mishima, Marcus Conrad
Annual Review of Nutrition (2022) Vol. 42, Iss. 1, pp. 275-309
Closed Access | Times Cited: 63
Eikan Mishima, Marcus Conrad
Annual Review of Nutrition (2022) Vol. 42, Iss. 1, pp. 275-309
Closed Access | Times Cited: 63
Regulated IRE1α-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer
Aitor Almanza, Katarzyna Mnich, Arnaud Blomme, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 54
Aitor Almanza, Katarzyna Mnich, Arnaud Blomme, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 54
Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer
Xuan Liu, Yiqian Zhang, Xuyi Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 45
Xuan Liu, Yiqian Zhang, Xuyi Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 45
ATF6α promotes prostate cancer progression by enhancing PLA2G4A‐mediated arachidonic acid metabolism and protecting tumor cells against ferroptosis
Ru Zhao, Ye Lv, Tingting Feng, et al.
The Prostate (2022) Vol. 82, Iss. 5, pp. 617-629
Open Access | Times Cited: 44
Ru Zhao, Ye Lv, Tingting Feng, et al.
The Prostate (2022) Vol. 82, Iss. 5, pp. 617-629
Open Access | Times Cited: 44
Lipid metabolism alterations and ferroptosis in cancer: Paving the way for solving cancer resistance
Jaewang Lee, Daiha Shin, Jong‐Lyel Roh
European Journal of Pharmacology (2023) Vol. 941, pp. 175497-175497
Closed Access | Times Cited: 31
Jaewang Lee, Daiha Shin, Jong‐Lyel Roh
European Journal of Pharmacology (2023) Vol. 941, pp. 175497-175497
Closed Access | Times Cited: 31
Fasting-mimicking diet synergizes with ferroptosis against quiescent, chemotherapy-resistant cells
Xiaoxia Liu, Shaoyong Peng, Guannan Tang, et al.
EBioMedicine (2023) Vol. 90, pp. 104496-104496
Open Access | Times Cited: 30
Xiaoxia Liu, Shaoyong Peng, Guannan Tang, et al.
EBioMedicine (2023) Vol. 90, pp. 104496-104496
Open Access | Times Cited: 30
Targeting Nrf2 for ferroptosis-based therapy: Implications for overcoming ferroptosis evasion and therapy resistance in cancer
Jaewang Lee, Jong‐Lyel Roh
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 7, pp. 166788-166788
Closed Access | Times Cited: 29
Jaewang Lee, Jong‐Lyel Roh
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 7, pp. 166788-166788
Closed Access | Times Cited: 29
Unraveling ETC complex I function in ferroptosis reveals a potential ferroptosis-inducing therapeutic strategy for LKB1-deficient cancers
Chao Mao, Guang Lei, Amber D. Horbath, et al.
Molecular Cell (2024) Vol. 84, Iss. 10, pp. 1964-1979.e6
Closed Access | Times Cited: 14
Chao Mao, Guang Lei, Amber D. Horbath, et al.
Molecular Cell (2024) Vol. 84, Iss. 10, pp. 1964-1979.e6
Closed Access | Times Cited: 14
Metabolic adaptations in prostate cancer
Mikel Pujana-Vaquerizo, Laura Bozal-Basterra, Arkaitz Carracedo
British Journal of Cancer (2024) Vol. 131, Iss. 8, pp. 1250-1262
Open Access | Times Cited: 13
Mikel Pujana-Vaquerizo, Laura Bozal-Basterra, Arkaitz Carracedo
British Journal of Cancer (2024) Vol. 131, Iss. 8, pp. 1250-1262
Open Access | Times Cited: 13